Spyre Therapeutics, Inc. - stock earnings
Stock symbol AGLE is outdated, potentially delisted? Maybe it is available on other exchange?
AGLE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -18.8 million USD | 168000 USD |
| 2022Q3 | -18.2 million USD | 174000 USD |
| 2022Q2 | -22.3 million USD | 625000 USD |
| 2022Q1 | -24.4 million USD | 1.4 million USD |
| 2021Q4 | -20.4 million USD | 3.6 million USD |
| 2021Q3 | -20.3 million USD | 1.4 million USD |
| 2021Q2 | -6.8 million USD | 13.7 million USD |
| 2021Q1 | -18.2 million USD | ? USD |
| 2020Q4 | -22.7 million USD | ? USD |
| 2020Q3 | -18.0 million USD | ? USD |
AGLE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -83.8 million USD | 2.3 million USD |
| 2021 | -65.8 million USD | 18.7 million USD |
| 2020 | -80.9 million USD | ? USD |
| 2019 | -78.3 million USD | ? USD |
| 2018 | -44.3 million USD | 3.9 million USD |
| 2017 | -27.2 million USD | 5.2 million USD |
AGLE
Price: $12.01
52 week price:
Earnings Per Share: -1.84 USD
P/E Ratio: -4.70
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 59052
Ebitda: -7.9 millionMarket Capitalization: 48.6 million